MedTrace Logo

Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients

NCT04465552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 666

Last updated 2021-09-20

No results posted yet for this study

Summary

Although arrhythmias appear to be common in COVID-19 patients, arrhythmia mechanisms and characteristics, predisposing factors, incidence of sudden cardiac death and predictors, therapeutic strategies employed as well as long term outcomes are not well understood. Hence, we seek to develop a multicenter registry aimed to characterize arrhythmic manifestations, employed treatment strategies and long-term outcomes among hospitalized COVID-19 patients in the US.

Conditions

  • Coronavirus Infections

Interventions

OTHER

Patients received standard of care treatment during hospitalization

All patients admitted with covid-19 will be enrolled and followed for the duration of their hospitalization as well as during outpatient follow for up to 6 months, in those recovered, to assess clinical outcomes.

Sponsors & Collaborators

  • Kansas City Heart Rhythm Research Foundation

    lead OTHER

Principal Investigators

  • Rakesh Gopinathannair, MD · Kansas City Heart Rhythm Research Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-10
Primary Completion
2021-01-24
Completion
2021-01-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04465552 on ClinicalTrials.gov